CELMoDs – The Future of Multiple Myeloma Treatment..

创建了一篇新文章

35 在

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID | #healthcare

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID

The field of multiple myeloma treatment is advancing rapidly, with CELMoDs (Cereblon E3 Ligase Modulators) emerging as a powerful alternative to Revlimid.

喜欢不喜欢

评论

分享